RE:YOUTH offers a non-surgical, regenerative stem cell therapy for liver cirrhosis, aiming to slow disease progression, reduce fibrosis, and support liver tissue regeneration. This advanced treatment provides a restorative option for patients with chronic liver damage who seek alternatives to transplantation or long-term medication. By targeting the cellular mechanisms behind liver scarring and inflammation, this therapy promotes functional recovery and improved liver performance. Key benefits include: ✔ Reduction in hepatic inflammation and fibrotic scarring ✔ Regeneration of damaged liver tissue ✔ Improved liver enzyme levels and metabolic function ✔ Delay in progression to end-stage liver disease ✔ Non-surgical, low-risk approach with personalized care This therapy is ideal for patients with early to moderate stage cirrhosis, including cases caused by hepatitis, alcohol, NAFLD, or autoimmune conditions. It may also benefit patients not eligible for liver transplant but seeking to maintain or improve quality of life.